Resveratrol protects rabbit ventricular myocytes against oxidative stress-induced arrhythmogenic activity and Ca2+ overload

Acta Pharmacologica Sinica

Volumn 34, Issue 9, 2013, Pages 1164-1173

  Li, Wei ^a   Wang, Yue Peng ^a   Gao, Ling ^b   Zhang, Peng Pai ^a   Zhou, Qing ^a   Xu, Quan Fu ^a   Zhou, Zhi Wen ^a   Guo, Kai ^a   Chen, Ren Hua ^a   Yang, Huang Tian ^b   Li, Yi Gang ^a  

^a SHANGHAI JIAO TONG UNIVERSITY   (China)

^b SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Ca2+ overload; CaMKII; Cardiac arrhythmias; Cardioprotective agents; L type calcium current; Late sodium current; Oxidative stress; Resveratrol

Indexed keywords

CALCIUM ION; RESVERATROL;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIARRHYTHMIC ACTIVITY; ARRHYTHMOGENESIS; ARTICLE; CALCIUM METABOLISM; CELL PROTECTION; CONTROLLED STUDY; DOSE RESPONSE; HEART DEPOLARIZATION; HEART MUSCLE CELL; MALE; NONHUMAN; OXIDATIVE STRESS; WESTERN BLOTTING;

ANIMALS; ARRHYTHMIAS, CARDIAC; CALCIUM; CELLS, CULTURED; HEART VENTRICLES; MALE; MYOCYTES, CARDIAC; OXIDATIVE STRESS; RABBITS; REACTIVE OXYGEN SPECIES; STILBENES;

EID: 84883735342     PISSN: 16714083     EISSN: 17457254     Source Type: Journal    
DOI: 10.1038/aps.2013.82     Document Type: Article

References (33)

1. Kinugawa S, Tsutsui H, Hayashidani S, Ide T, Suematsu N, Satoh S, et al. Treatment with dimethylthiourea prevents left ventricular remodeling and failure after experimental myocardial infarction in mice: role of oxidative stress. Circ Res 2000; 87: 392-8.
2. Xin P, Pan Y, Zhu W, Huang S, Wei M, Chen C. Favorable effects of resveratrol on sympathetic neural remodeling in rats following myocardial infarction. Eur J Pharmacol 2010; 649: 293-300.
3. Mallat Z, Philip I, Lebret M, Chatel D, Maclouf J, Tedgui A. Elevated levels of 8-iso-prostaglandin F2alpha in pericardial fluid of patients with heart failure: a potential role for in vivo oxidant stress in ventricular dilatation and progression to heart failure. Circulation 1998; 97: 1536-9.
4. Song Y, Shryock JC, Wagner S, Maier LS, Belardinelli L. Blocking late sodium current reduces hydrogen peroxide-induced arrhythmogenic activity and contractile dysfunction. J Pharmacol Exp Ther 2006; 318: 214-22.
5. Wagner S, Seidler T, Picht E, Maier LS, Kazanski V, Teucher N, et al. Na+-Ca2+ exchanger overexpression predisposes to reactive oxygen species-induced injury. Cardiovasc Res 2003; 60: 404-12.
6. Wagner S, Ruff HM, Weber SL, Bellmann S, Sowa T, Schulte T, et al. Reactive oxygen species-activated Ca/calmodulin kinase IIdelta is required for late INa augmentation leading to cellular Na and Ca overload. Circ Res 2011; 108: 555-65.
7. Xie LH, Chen F, Karagueuzian HS, Weiss JN. Oxidative-stress-induced afterdepolarizations and calmodulin kinase II signaling. Circ Res 2009; 104: 79-86.
8. Erickson JR, Joiner ML, Guan X, Kutschke W, Yang J, Oddis CV, et al. A dynamic pathway for calcium-independent activation of CaMKII by methionine oxidation. Cell 2008; 133: 462-74.
9. Song YH, Choi E, Park SH, Lee SH, Cho H, Ho WK, et al. Sustained CaMKII activity mediates transient oxidative stress-induced long-term facilitation of L-type Ca2+ current in cardiomyocytes. Free Radic Biol Med 2011; 51: 1708-16.
10. Zhao Z, Fefelova N, Shanmugam M, Bishara P, Babu GJ, Xie LH. Angiotensin II induces afterdepolarizations via reactive oxygen species and calmodulin kinase II signaling. J Mol Cell Cardiol 2011; 50: 128-36.
11. Husken A, Baumert A, Milkowski C, Becker HC, Strack D, Mollers C. Resveratrol glucoside (Piceid) synthesis in seeds of transgenic oilseed rape (Brassica napus L). Theor Appl Genet 2005; 111: 1553-62.
12. Bhat KPL, Kosmeder JW 2nd, Pezzuto JM. Biological effects of resveratrol. Antioxid Redox Signal 2001; 3: 1041-64.
13. Movahed A, Yu L, Thandapilly SJ, Louis XL, Netticadan T. Resveratrol protects adult cardiomyocytes against oxidative stress mediated cell injury. Arch Biochem Biophys 2012; 527: 74-80.
14. Thandapilly SJ, Wojciechowski P, Behbahani J, Louis XL, Yu L, Juric D, et al. Resveratrol prevents the development of pathological cardiac hypertrophy and contractile dysfunction in the SHR without lowering blood pressure. Am J Hypertens 2010; 23: 192-6.
15. Renaud S, de Lorgeril M. Wine, alcohol, platelets, and the French paradox for coronary heart disease. Lancet 1992; 339: 1523-6.
16. Chen YR, Yi FF, Li XY, Wang CY, Chen L, Yang XC, et al. Resveratrol attenuates ventricular arrhythmias and improves the long-term survival in rats with myocardial infarction. Cardiovasc Drugs Ther 2008; 22: 479-85.
17. Chen WP, Su MJ, Hung LM. In vitro electrophysiological mechanisms for antiarrhythmic efficacy of resveratrol, a red wine antioxidant. Eur J Pharmacol 2007; 554: 196-204.
18. Lakatta EG, Sollott SJ. The "heartbreak" of older age. Mol Interv 2002; 2: 431-46.
19. Zhang CM, Gao L, Zheng YJ, Yang HT. Berbamine increases myocardial contractility via a Ca2+-independent mechanism. J Cardiovasc Pharmacol 2011; 58: 40-8.
20. Janiak R, Lewartowski B. Early after-depolarisations induced by noradrenaline may be initiated by calcium released from sarcoplasmic reticulum. Mol Cell Biochem 1996; 163-164: 125-30.
21. Sag CM, Wadsack DP, Khabbazzadeh S, Abesser M, Grefe C, Neumann K, et al. Calcium/calmodulin-dependent protein kinase II contributes to cardiac arrhythmogenesis in heart failure. Circ Heart Fail 2009; 2: 664-75.
22. Gonano LA, Sepulveda M, Rico Y, Kaetzel M, Valverde CA, Dedman J, et al. Calcium-calmodulin kinase II mediates digitalis-induced arrhythmias. Circ Arrhythm Electrophysiol 2011; 4: 947-57.
23. Dallas ML, Yang Z, Boyle JP, Boycott HE, Scragg JL, Milligan CJ, et al. Carbon monoxide induces cardiac arrhythmia via induction of the late Na+ current. Am J Respir Crit Care Med 2012; 186: 648-56.
24. Wu L, Ma J, Li H, Wang C, Grandi E, Zhang P, et al. Late sodium current contributes to the reverse rate-dependent effect of IKr inhibition on ventricular repolarization. Circulation 2011; 123: 1713-20.
25. Qi X, Yeh YH, Chartier D, Xiao L, Tsuji Y, Brundel BJ, et al. The calcium/calmodulin/kinase system and arrhythmogenic afterdepolarizations in bradycardia-related acquired long-QT syndrome. Circ Arrhythm Electrophysiol 2009; 2: 295-304.
26. Morita N, Lee JH, Xie Y, Sovari A, Qu Z, Weiss JN, et al. Suppression of re-entrant and multifocal ventricular fibrillation by the late sodium current blocker ranolazine. J Am Coll Cardiol 2011; 57: 366-75.
27. Ashpole NM, Herren AW, Ginsburg KS, Brogan JD, Johnson DE, Cummins TR, et al. Ca2+/calmodulin-dependent protein kinase II (CaMKII) regulates cardiac sodium channel NaV1.5 gating by multiple phosphorylation sites. J Biol Chem 2012; 287: 19856-69.
28. Zhang Y, Liu Y, Wang T, Li B, Li H, Wang Z, et al. Resveratrol, a natural ingredient of grape skin: antiarrhythmic efficacy and ionic mechanisms. Biochem Biophys Res Commun 2006; 340: 1192-9.
29. Guo D, Lian J, Liu T, Cox R, Margulies KB, Kowey PR, et al. Contribution of late sodium current (INa-L) to rate adaptation of ventricular repolarization and reverse use-dependence of QT-prolonging agents. Heart Rhythm 2011; 8: 762-9.
30. Yao L, Fan P, Jiang Z, Viatchenko-Karpinski S, Wu Y, Kornyeyev D, et al. Nav1.5-dependent persistent Na+ influx activates CaMKII in rat ventricular myocytes and N1325S mice. Am J Physiol Cell Physiol 2011; 301: C577-86.
31. Coppini R, Ferrantini C, Yao L, Fan P, Del Lungo M, Stillitano F, et al. Late sodium current inhibition reverses electromechanical dysfunction in human hypertrophic cardiomyopathy. Circulation 2013; 127: 575-84.
32. Wagner S, Rokita AG, Anderson ME, Maier LS. Redox regulation of sodium and calcium handling. Antioxid Redox Signal 2013; 18: 1063-77.
33. Anzai K, Ogawa K, Kuniyasu A, Ozawa T, Yamamoto H, Nakayama H. Effects of hydroxyl radical and sulfhydryl reagents on the open probability of the purified cardiac ryanodine receptor channel incorporated into planar lipid bilayers. Biochem Biophys Res Commun 1998; 249: 938-42.